Clinical uptake of an antigen-based approach to membranous nephropathy: a survey of general nephrologists and glomerular disease experts
Although many new MN antigens have been discovered, there is limited availability of tests identifying these less common antigens. While the survey suggests potential for utilization of an antigen-tailored approach based on identified differences in screening and treatment practices, there remains a lag in the full adoption of this new information. Further progress in accessibility of antigen testing and research into antigen associations will enable a more individualized approach to the management of MN.
Authors
- Bryce Barr (ORCID: https://orcid.org/0000-0002-1159-978X)
- Georges Nakhoul (ORCID: https://orcid.org/0000-0002-8997-1940)
- Eibhlin S. Goggins (ORCID: https://orcid.org/0000-0001-7952-7726)
- Brendan Bowman (ORCID: https://orcid.org/0000-0003-2322-179X)
- Ali Mehdi (ORCID: https://orcid.org/0000-0002-9073-204X)
- Andrew DeLaat
- Corey Cavanaugh (ORCID: https://orcid.org/0000-0001-7504-038X)
- Jonathan J. Taliercio (ORCID: https://orcid.org/0000-0003-4320-7151)
Institutions
- Cleveland Clinic (US)
- Riverside Methodist Hospital (US)
- Cleveland Foundation (US)
- Center for Neuroscience and Regenerative Medicine (US)
- University of Manitoba (CA)
Publication Details
- Journal
- Journal of Nephrology
- Published
- 2025-06-11
- DOI
- https://doi.org/10.1007/s40620-025-02313-6
- Citations
- 1
- Primary Topic
- Renal Diseases and Glomerulopathies
- Type
- article
- Field-Weighted Citation Impact
- 1.43